340 related articles for article (PubMed ID: 34996469)
1. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m
Xu Y; Lv D; Yan C; Su H; Zhang X; Shi Y; Ying K
Cancer Cell Int; 2022 Jan; 22(1):11. PubMed ID: 34996469
[TBL] [Abstract][Full Text] [Related]
2. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
3. Targeting SLC3A2 subunit of system X
Ma L; Zhang X; Yu K; Xu X; Chen T; Shi Y; Wang Y; Qiu S; Guo S; Cui J; Miao Y; Tian X; Du L; Yu Y; Xia J; Wang J
Free Radic Biol Med; 2021 May; 168():25-43. PubMed ID: 33785413
[TBL] [Abstract][Full Text] [Related]
4. METTL3 exerts synergistic effects on m6A methylation and histone modification to regulate the function of VGF in lung adenocarcinoma.
Shi K; Sa R; Dou L; Wu Y; Dong Z; Fu X; Yu H
Clin Epigenetics; 2023 Sep; 15(1):153. PubMed ID: 37742030
[TBL] [Abstract][Full Text] [Related]
5. The essential roles of m
Ma L; Xue X; Zhang X; Yu K; Xu X; Tian X; Miao Y; Meng F; Liu X; Guo S; Qiu S; Wang Y; Cui J; Guo W; Li Y; Xia J; Yu Y; Wang J
J Exp Clin Cancer Res; 2022 Jan; 41(1):36. PubMed ID: 35078505
[TBL] [Abstract][Full Text] [Related]
6. The m
Ma L; Chen T; Zhang X; Miao Y; Tian X; Yu K; Xu X; Niu Y; Guo S; Zhang C; Qiu S; Qiao Y; Fang W; Du L; Yu Y; Wang J
Redox Biol; 2021 Jan; 38():101801. PubMed ID: 33232910
[TBL] [Abstract][Full Text] [Related]
7. m
Xu L; Li Q; Wang Y; Wang L; Guo Y; Yang R; Zhao N; Ge N; Wang Y; Guo C
Am J Cancer Res; 2021; 11(11):5282-5298. PubMed ID: 34873461
[TBL] [Abstract][Full Text] [Related]
8. Silencing of METTL3 suppressed ferroptosis of myocardial cells by m6A modification of SLC7A11 in a YTHDF2 manner.
Tang Z; Huang X; Mei H; Zheng Z
J Bioenerg Biomembr; 2024 Apr; 56(2):149-157. PubMed ID: 38319402
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine writer METTL3 accelerates the sepsis-induced myocardial injury by regulating m6A-dependent ferroptosis.
Shen H; Xie K; Tian Y; Wang X
Apoptosis; 2023 Apr; 28(3-4):514-524. PubMed ID: 36645573
[TBL] [Abstract][Full Text] [Related]
10. Hsa_circ_0070440 promotes lung adenocarcinoma progression by SLC7A11-mediated-ferroptosis.
Zhao Y; Cui Q; Shen J; Shen W; Weng Y
Histol Histopathol; 2023 Dec; 38(12):1429-1441. PubMed ID: 36852950
[TBL] [Abstract][Full Text] [Related]
11. METTL3-mediated m
Wu Y; Chang N; Zhang Y; Zhang X; Xu L; Che Y; Qiao T; Wu B; Zhou Y; Jiang J; Xiong J; Zhang J; Zhang J
J Exp Clin Cancer Res; 2021 Mar; 40(1):90. PubMed ID: 33676554
[TBL] [Abstract][Full Text] [Related]
12. Bulk RNA-seq and scRNA-seq reveal SLC7A11, a key regulatory molecule of ferroptosis, is a prognostic-related biomarker and highly related to the immune system in lung adenocarcinoma.
Wu X; Wang S; Chen K
Medicine (Baltimore); 2023 Sep; 102(37):e34876. PubMed ID: 37713821
[TBL] [Abstract][Full Text] [Related]
13. CircP4HB regulates ferroptosis via SLC7A11-mediated glutathione synthesis in lung adenocarcinoma.
Pan CF; Wei K; Ma ZJ; He YZ; Huang JJ; Guo ZZ; Chen ZP; Barr MP; Shackelford RE; Xia Y; Wang J
Transl Lung Cancer Res; 2022 Mar; 11(3):366-380. PubMed ID: 35399564
[TBL] [Abstract][Full Text] [Related]
14. Up-regulated ORC1 promotes lung adenocarcinoma by inhibiting ferroptosis via SLC7A11 dependent pathway.
Ming L; Han Z; Ai Z; Yang X; Lin F; Zhang N; Hao W
Heliyon; 2024 May; 10(9):e30506. PubMed ID: 38756571
[TBL] [Abstract][Full Text] [Related]
15. N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability.
Ji Y; Zhao Q; Feng W; Peng Y; Hu B; Chen Q
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428672
[TBL] [Abstract][Full Text] [Related]
16. HIF-1α-induced expression of the m6A reader YTHDF1 inhibits the ferroptosis of nucleus pulposus cells by promoting SLC7A11 translation.
Lu X; Li D; Lin Z; Gao T; Gong Z; Zhang Y; Wang H; Xia X; Lu F; Song J; Xu G; Jiang J; Ma X; Zou F
Aging Cell; 2024 May; ():e14210. PubMed ID: 38783692
[TBL] [Abstract][Full Text] [Related]
17. DUSP5 regulated by YTHDF1-mediated m6A modification promotes epithelial-mesenchymal transition and EGFR-TKI resistance via the TGF-β/Smad signaling pathway in lung adenocarcinoma.
Fan W; Xing Y; Yan S; Liu W; Ning J; Tian F; Wang X; Zhan Y; Luo L; Cao M; Huang J; Cai L
Cancer Cell Int; 2024 Jun; 24(1):208. PubMed ID: 38872157
[TBL] [Abstract][Full Text] [Related]
18. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
19. LncRNA AC098934 promotes proliferation and invasion in lung adenocarcinoma cells by combining METTL3 and m6A modifications.
Huang S; Jin M; Lan X; Wu JL; Zhang Z; Zhao J; Li Y
J Cancer; 2022; 13(8):2662-2672. PubMed ID: 35711823
[No Abstract] [Full Text] [Related]
20. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
